Wake-up haul: an Ozempic moment for the brain
Orexins are peptides involved in the body’s sleep-wake system—and are big pharma’s next big thing. Like multi-purpose GLPs, they may have far more uses than just regulating shuteye. We ask why Japan’s post-war innovation boom petered out, and what must be done to breed more unicorns. And why procrastination seems to…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Economist Podcasts →
The Weight Loss Drug Revolution: Transforming Bodies and Reshaping Economies | The Global Brief
57%China's booming biotech, from a brain implant to drug discovery
The Big Tech earnings dilemma
$1B GLP-1 Lessons, New AI Careers, China's 2030 Master Plan | Sam Broner, Jonathan Slotkin, Liz Hoffman, Bret Taylor, Ariyan Kabir, Atif Siddiqi
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.